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ABSTRACT
Background: Endoscopic biopsy of the gastric mucosa allows early diagnosis, grading, 
staging and classification of gastric diseases. Helicobacter pylori, has been recognized 
as a major aetiologic factor for chronic gastritis, benign gastric ulcers and gastric 
adenocarcinoma and lymphoma. The loco-regional variability in the prevalence 
of Helicobacter pylori and associated diseases in Nigeria, emphasise the need for 
evaluation of subsets of a heterogeneous population like ours
Objective: To determine the frequency of helicobacter pylori in gastric endoscopic 
biopsies and document the pathology of gastric lesions commonly associated with 
Helicobacter pylori infection.
Design: Retrospective descriptive study.
Settings:  University of Benin Teaching Hospital (UBTH), and Biogenics Histopathology 
Laboratory (a private Histopathology Laboratory), both based in Benin City, Niger 
Delta region of Nigeria.
Subjects: Endoscopic gastric biopsies recorded in the surgical pathology register of 
the department from 2005-2009 were studied and relevant demographic and clinical 
information extracted from the registers, original request cards and patient case 
files. The clinical data and slides processed from paraffin embedded tissue blocks 
of endoscopic biopsies of gastric lesions seen from year 2005 to 2009 were studied, 
analyzed and statistically presented.
Results: Total number of specimens studied was 142. Chronic gastritis was present 
in 117(82.39%) specimens; 9(6.34%) were benign gastric ulcers; 3(2.11%) were gastric 
polyps; and 11(7.75%) were gastric malignancies. Helicobacter pylori, was demonstrated 
in 55.6% of all specimens. The peak age for Chronic Gastritis and Gastric Cancer is the 
6th decade. Amongst patients with chronic gastritis, inflammatory activity was present 
in 65%; atrophy in 53%; and intestinal metaplasia in 16.6%. All gastric malignancies 
seen were intestinal type adenocarcinomas. 
Conclusion: The spectrum of lesions diagnosed in gastric endoscopic biopsy specimens 
in Benin, their frequency and associations are largely comparable to what has been 
described elsewhere in Nigeria and Africa.
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INTRODUCTION
Helicobacter Pylori is associated with approximately 
80%-90% of cases of chronic gastritis worldwide1. 
H. Pylori gastritis confers a 15%-20% lifetime risk of 
developing peptic ulcer disease. It is found in 95% 
of duodenal ulcers and 70-80% of gastric ulcers2. 
Helicobacter pylori, was named a group 1 (definite) 
carcinogen in 1994 by the International Agency for 
Research on cancer (IARC). Forty three to eighty 
three percent of gastric carcinoma biopsies and 
approximately 90% of Mucosa Associated Lymphoid 
Tissue (MALT) lymphoma biopsies have been found 
to be positive for Helicobacter pylori3. 
 The prevalence of H. Pylori infection in adults 
approaches 90% in developing countries, particularly 
in the tropics where exposure occurs relatively early in 
life. In industrialized nations exposure tends to occur 
later in life with lower percentage of infected adults 
(20%- 30% by age 50). The prevalence has been steadily 
declining in industrialized and emerging countries 
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probably due to increased sanitary conditions. 
However, despite declining rates of the infection in 
general the prevalence rates of H. Pylori in patients 
who undergo endoscopy remain significant (4).
 In Japan, Sepulveda and Coelho prospectively 
studied 1526 cases.  One thousand two hundred and 
forty-six patients were found to be H pylori positive. 
Out of these, 36 (2.9%) developed carcinoma over a 
mean follow up period of 7.8 years. Twenty-three were 
intestinal type cancers, 13 were diffuse5. None of the 
280 H pylori negative patients developed cancer.  
 Caputo et al did a 10 year review of 60 biopsies 
with diagnoses of gastric adenocarcinoma. H pylori 
was found in 35 (58%) of the analyzed biopsies. 
Twenty-four of the 35 H pylori positive cases were of 
intestinal type, 9 were diffuse adenocarcinoma, and, 
2 were mixed (6).
 In a series of 31 MALTomas, Bouzourene et al, 
recorded 18(58%), Helicobacter pylori positive cases7. 
Wotherspoon et al (United Kingdom) and Stolle et al 
(Germany) demonstrated stronger associations. They 
found histologic evidence of H pylori infection in 92% 
and 98% respectively amongst patients with gastric 
lymphomas8, (9).
 Although, some work has been done in Nigeria 
in some of our tertiary health/academic institutions, 
there is a need for continued evaluation of subsets of 
a heterogeneous population like ours. With increasing 
availability of endoscopic services in Nigeria, data 
collection and evaluation has become imperative, 
to provide a basis for the adoption of recommended 
diagnostic, prognostic and therapeutic guidelines for 
the management of H. pylori associated lesions and 
gastric diseases in general.
MATERIALS AND METHODS
This is a  five year (January, 2005-December, 2009) 
retrospective, descriptive study of gastric lesions 
reported in the Department of Morbid Anatomy, 
University of Benin Teaching Hospital (UBTH), 
and Biogenics histopathology Laboratory(a private 
Histopathology Laboratory based in Benin) . 
 Endoscopic gastric biopsies recorded in the 
surgical pathology register of the department from 
2005-2009 were studied and relevant demographic 
and clinical information extracted from the registers, 
original request cards and patient case files.
 Original slides were retrieved and reviewed. 
All available formalin fixed and paraffin embedded 
tissue blocks of gastric endoscopic biopsies within this 
period were resectioned at 2-3µm and stained with 
Haematoxylin and Eosin. Modified Giemsa stain, and 
Alcian blue/ PAS stain were used for verification of 
Helicobacter pylori and demonstration of intestinal 
metaplasia respectively.  All biopsies with missing 
blocks were excluded.
 Biopsies were classified using the Updated 
Sydney system of classification of gastritis10 and the 
WHO and Lauren classification of gastric cancers11, 
12. The pathological reports and diagnoses of all cases 
studied were reviewed, and all cases reconfirmed, 
classified and graded.
 Statistical analysis was done with SPSS11.0for 
windows. Results were presented in simple 
frequencies and a P < 0.05 was considered statistically 
significant.
RESULTS
A total of 13,255 biopsies were received at the 
Morbid Anatomy Department of the University of 
Benin Teaching Hospital (UBTH) and The Biogenics 
Histopathology Laboratory over the five year period 
of this study. The total gastrointestinal specimen was 
2,554 out of which 292 were of gastric origin. Out 
of the 292 gastric specimens, 238 were endoscopic 
biopsies, of these, only 142 cases had tissue blocks 
and clinical data available, these constituted our 
study population.
 Of the 142 patients, 74 were males (52.1%) and 
68 were females (47.9%). The male female ratio 
was 1.1:1.The ages of this study population (Table 
I and Figure I), range between 15 and 86 years. The 
modal age group was 50 – 59 years. The mean age 
is 48.6 years +1.52 SD). the mean age for males and 
females are 47.4 years+ 1.46 SD and 49.9 years +1.58 
SD respectively. p-value =0.123.
 The cases with histological diagnosis of Chronic 
Gastritis were 117 (82.39%), other non cancerous 
Gastric Lesions were 12 (8.45%), normal Gastric 
biopsies were 2 (1.41%) and gastric Malignancies 
were 11 (7.75%). 
 The overall rate of Helicobacter pylori is 
79(55.6%) out of 142 patients.
 For the 117 patients with chronic gastritis, the 
age range was between 15 and 86 years, mean was 
48.6 years+1.56 SD and modal age group was 50-59 
years (Table I and Figure 1). There were 60 males and 
57 females. Male to female ratio was 1.05:1.
 Seventy four (63.2%) of the patients with chronic 
gastritis had antral biopsies only, 26(22.2%) had 
corporal biopsies only, while 17(14.5%) cases has both 
antral and corporal biopsies. Analysis of all biopsies 
showed a total of 91 antral biopsies and 43 corporal 
biopsies. Further analyses of the 17 cases with both 
antral and corporal biopsies showed, pangastritis in 
15(88.2%) cases, while 2(11.8%) cases had gastritis 
restricted to the antrum. Chronic Inflammation was 
mild in 10 cases (8.5%); moderate in 56 cases (47.9%); 
and marked in 51 cases (43.6%). 
 The frequency of Helicobacter pylori positivity 
in patients with Chronic Gastritis was 69(59.0%). 
Density of H. pylori was mild in 21(17.9%), moderate 
in 30(25.65%), and marked in 18(15.4%) of cases (Table 
II). The 69 patients with H. pylori positive biopsies 
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were made up of 38 males (64.4%) and 31 females (35. 
6%). H. Pylori colonization is not recorded in the 0-9 
year age group. Thereafter it steadily rises, peaks in 
the 40-49years age group (a decade before the modal 
age for chronic gastritis and gastric malignancies), 
then slowly declines (Figure II).
 Neutrophil infiltrates (activity) were present in 
76 cases (65%) while 41 cases (35%) were non active. 
Glandular atrophy was present in 62cases (53%), while 
55 patients had non-atrophic chronic gastritis. Only 
19 (16.3%) patients had intestinal metaplasia (Table 
II).
 Other Gastric Lesions seen are 9 cases of Gastric 
Ulcers and 3 cases of Gastric Hyperplastic Polyps 
making up 12 cases (9.16% of all lesions seen - Table 
I). There were 6 Males and 6 Females. Age range was 
15years to 72years. The ulcer edge biopsies were antral 
biopsies in 6 cases and corporal biopsies in 3 cases. 
They were from 4 males and 5 females. All showed 
some degree of atrophy, and 6 cases had varying 
densities of H. pylori colonization.  The three polyps 
were from 2 males and 1 female. 2 were antral polyps, 
and 1 was a polyp from the corpus which showed 
mild H. pylori colonisation. 
 There are 11 cases of gastric cancers seen in this 
study consisting of 7 males and 4 females with a M: 
F ratio of 1.75:1. The age range is 40- 72years with 
a mean of 52.7years and peak age group being 50-
59years (Figure I). 
 All cases were intestinal type adenocarcinoma. 
They were six cases of tubular adenocarcinomas 
(54.5%); two papillary adenocarcinomas (18.2%); 
two solid-type adenocarcinomas (18.2%) and one 
mucinous adenocarcinoma (9.1%). Seven of the 
tumours were from the antrum while four were from 
the corpus.
Table 1












0-9 - - - - -
10-19 1 1 - - 2(1.4%)
20-29 8 1 - - 9(6.3%)
30-39 12 1 - - 13(9.2%)
40-49 25 3 2 1 31(21.8%)
50-59 32 2 5 1 40(28.2%)
60-69 22 2 3 - 27(19.0%)
70-79 12 2 1 - 15(10.6%)
80-89 5 - - - 5(3.5%)
Total 117(82.39%)  12(8.45%) 11 (7.75%) 2(1.41%) 142(100%)
Table 2
 Frequency analyses of graded variables in chronic gastritis
Variable None Mild Moderate Marked Total
Chronic Inflammation  0(0%) 10(8.5%) 56(47.9%) 51(43.6%) 117(100%)
Activity 41(35.1%) 30(25.6%) 28(23.9%) 18(15.4%) 117(100%)
Atrophy 55(47.0%) 20(17.1%) 40(34.2%) 2(1.7%) 117(100%)
Intestinal Metaplasia 96(83.8%) 5(4.3%) 9(7.7%) 5(4.3%) 117(100%)
Helicobacter Pylori 48(41.0%) 21(17.9%) 30(25.6%) 18(15.4%) 117(100%)




Age distribution of H.pylori positive chronic gastritis patients
DISCUSSION
This study evaluates the histopathological features of 
H. Pylori associated gastric lesions as seen in gastric 
endoscopic biopsies taken in Benin City. 
 A total of 142 specimens were seen; 117 (82.39%) had 
a diagnosis of chronic gastritis; 9(6.34%) were gastric 
ulcer biopsies; 3(2.1%) were polyps; 11(7.75%) were 
gastric adenocarcinoma; and 2(1.4%) were normal 
biopsies.
The ages of the 117 patients with chronic gastritis 
ranged between 15 and 75 years. The mean age 
was 48.6 years and the modal age group was 50-59 
years. This mean age is similar to that recorded by 
Awolola in Lagos13 and Oluwasola in Ibadan14, 
Nigeria who reported mean ages of 48.9 years and 
44.4 years respectively. The modal age group in this 
study is 50-59years, the same age group reported 
by Oluwasola in Ibadan14, which is a decade later 
than that reported by Awolola in Lagos13. Chronic 
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gastritis was first noticed in the 2nd decade peaking 
in the 6th decade and tailing off in the 8th decade, 
this pattern is the same observed by Awolola and 
Oluwasola13, 14. This age distribution is mirrored in 
the Helicobacter pylori positive patients, though the 
peak age is a decade earlier. Studies from Europe and 
Japan showed that chronic gastritis is uncommon in 
children and young adults; this suggests a later age 
at acquisition of infection, but a higher percentage 
(approx. 90%) of persons, 60 years and above has 
some form of gastritis (15).
 The prevalence of Helicobacter Pylori amongst 
all patients in this study is 55.6%. It is slightly higher 
amongst patients with Chronic Gastritis (59%). This 
figure is high when compared to 42.1% recorded in 
the study of 114 patients by Awolola in Lagos south 
west Nigeria13; the 22.4% prevalence in the study by 
Oluwasola in Ibadan south west Nigeria14; or 25% 
in the Ugandan study by Warbinger16. However, the 
latter two studies were in smaller sample populations 
(85 and 56 patients respectively). Higher prevalence 
rates have been recorded in other studies from Nigeria 
and parts of Africa, Holcombe recorded 84% rate of 
Helicobacter pylori infection in M aiduguri17, while 
Diomande et.al in Cote d’ Ivore recorded 91.3%18. 
These findings show the wide variability in H. pylori 
prevalence recorded in different regions.
 The prevalence rate of Helicobacter pylori in, 
different studies is subject to, the accuracy of biopsy 
techniques. Taking into consideration, the sometimes 
patchy nature of gastritis, multiple biopsies are 
recommended to improve the yield. The usefulness 
of this recommendation is reflected in this study by 
the fact that patients with dual biopsies (antral and 
corpus) had a higher prevalence of Helicobacter pylori 
-64.7% amongst 17 patients. Awolola also recorded 
a higher prevalence of 47.8% amongst 23 patients 
with dual biopsies compared to 42.1% in total study 
population of 11 413.
 Most of our Helicobacter pylori positive patients 
had moderate to marked chronic inflammation; 
however a statistically significant relationship 
was not demonstrated between the density of 
Helicobacter pylori infection and the grade of chronic 
inflammation. This contrasts with the findings of 
Awolola in Lagos, and Oluwasola and Ogunbiyi 
in Ibadan13, 14. However, it is known that in some 
specimens, Helicobacter pylori may be found in 
the mucus or close to the mucosal cells with little 
or no inflammation though a repeat biopsy or 
multiple sampling will reveal inflammation and 
mucosal damage19. Furthermore possible recent 
use of antimicrobial therapy -which cannot be 
ruled out- often eradicates or decreases helicobacter 
pylori density, without immediate concomitant 
or commensurate disappearance of chronic 
inflammation10. These factors may cause a relative 
discordance between the density of Helicobacter 
pylori and the grade of chronic inflammation.
 The association between Helicobacter pylori 
infection and the presence of chronic inflammation 
in the mucosa is reflected in the age distribution 
of patients with chronic gastritis and that of the 
Helicobacter pylori infection population (Figure 1 
and 2). A general population based study, rather than 
a study based on dyspeptic/ symptomatic patients 
may better demonstrate statistically the significance/ 
strength of association.
 Other gastric lesions seen were nine cases 
of gastric ulcer biopsies (6.34%), and 3 gastric 
hyperplastic polyps (2.11%).  Out of 9 ulcers, 6 
(66.67%) were positive for Helicobacter pylori. Kidd 
et al. documented a 7% rate for gastric ulcer, 75% of 
these were H. Pylori positive in a series of 2286 cases 
(20).
Gastric polyps are commonly encountered during 
upper gastrointestinal endoscopy. In this series 
there were 3 polyps out of 142 specimens, all were 
hyperplastic polyps, and one was positive for 
Helicobacter pylori.  Hyperplastic polyps usually 
represent about 75% of gastric epithelial polyps and 
the frequency increases with age (21). 
 There are 11 cases of gastric cancers seen in this 
study consisting of 7 males and 4 females with a M: F 
ratio of 1.75:1. This sex distribution agrees with other 
studies that have documented that gastric cancer has 
a male predilection (20-22). 
 The age range of patients was 40 years to 72 
years. The mean age is 52.7 years and peak age was 
the 6th decade.  Nine (81.8%) out of 11 patients were 
50 years and above (Table I). These are similar to 
Awolola’s findings in Lagos. He documented mean 
age of 58.4 years; and a modal age group of 50-59 
years13. Oluwasola and Ogunbiyi in Ibadan also 
recorded a mean age of 55.8 years (14).
 All gastric cancers seen in this study were 
intestinal-type adenocarcinoma. Adenocarcinomas 
constitute approximately 90% of gastric cancers seen 
in most studies, and about 30% of adenocarcinomas 
usually are of the diffuse type23. Studies from the 
southwest and northern zones of Nigeria have 
reported that 56-73.3% of gastric malignancies are 
intestinal adenocarcinomas, and 22-25% are diffuse 
type13, 14, 24. The fact that only intestinal-type 
adenocarcinomas were seen in this study may be 
because of the small sample size (only 11 cases out 
of 20 endoscopically diagnosed tumours had blocks 
available for review. 
 Out of the eleven cases seen, there were two 
papillary adenocarcinomas (18.2%), two solid-
type adenocarcinomas (118.2%) and one mucinous 
adenocarcinoma (9.1%); the remaining six showed 
predominantly tubular pattern of growth with some 
having focal papillary or solid differentiation.
 Topographic distribution of the tumours is 
mainly antral. Seven tumours were from the antrum 
December 2012 East african MEdical Journal    413
while four tumours were from the corpus. Local 
studies show that 60-80% of gastric cancers in Nigeria 
are located in the antrum 24, 25, however, Awolola13 
and Obekpa et al26, documented a predominance of 
corporal tumours.
 Intestinal Adenocarcinomas are known to 
have almost 100% association with Helicobacter 
pylori. Evaluation of seven specimens that had 
non-cancerous adjacent mucosa showed three 
cases (42.8%) were positive for Helicobacter pylori. 
Although, our small sample may not well reflect the 
larger population, these rates are similar to what has 
been recorded in other parts of the country (13-14).
CONCLUSION
The spectrum of lesions diagnosed in gastric 
endoscopic biopsy specimens in Benin City, 
Nigeria, their frequency and associations are largely 
comparable to what has been described elsewhere in 
Nigeria and Africa.
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